Measuring antibody avidity to Plasmodium falciparum merozoite antigens using a multiplex immunoassay approach

Abstract Background Antibodies (Ab) play a significant role in immunity to Plasmodium falciparum malaria. Usually, following repeated exposure to pathogens, affinity maturation and clonal selection take place, resulting in increased antibody avidity. However, some studies suggest affinity maturation...

Full description

Bibliographic Details
Main Authors: Diane Wallace Taylor, Naveen Bobbili, Alex Kayatani, Samuel Tassi Yunga, Winifrida Kidima, Rose F. G. Leke
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Malaria Journal
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12936-020-03243-3
id doaj-2163c242a3ba494c9597dd6f36c4a105
record_format Article
spelling doaj-2163c242a3ba494c9597dd6f36c4a1052020-11-25T02:11:11ZengBMCMalaria Journal1475-28752020-05-0119111210.1186/s12936-020-03243-3Measuring antibody avidity to Plasmodium falciparum merozoite antigens using a multiplex immunoassay approachDiane Wallace Taylor0Naveen Bobbili1Alex Kayatani2Samuel Tassi Yunga3Winifrida Kidima4Rose F. G. Leke5Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School of Medicine, University of HawaiiDepartment of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School of Medicine, University of HawaiiDepartment of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School of Medicine, University of HawaiiDepartment of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School of Medicine, University of HawaiiDepartment of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School of Medicine, University of HawaiiFaculty of Medicine and Biomedical Sciences, The Biotechnology Center, University of Yaoundé 1Abstract Background Antibodies (Ab) play a significant role in immunity to Plasmodium falciparum malaria. Usually, following repeated exposure to pathogens, affinity maturation and clonal selection take place, resulting in increased antibody avidity. However, some studies suggest affinity maturation may not occur to malaria antigens in endemic areas. Information on development of antibody avidity is confusing and conflicting, in part, because different techniques have been used to measure avidity. Today, bead-based multiplex immunoassays (MIA) are routinely used to simultaneously quantitate antibody levels to multiple antigens. This study evaluated the feasibility of developing an avidity MIA with 5 merozoite antigens (AMA1, EBA-175, MSP1-42, MSP2, MSP3) that uses a single chaotropic concentration. Methods The most common ELISA protocols that used the chaotropic reagents guanidine HCl (GdHCl), urea, and ammonium thiocyanate (NH4SCN) were adapted to a multiplex MIA format. Then, different concentrations of chaotropes and incubation times were compared and results were expressed as an Avidity Index (AI), i.e., percentage of antibody remaining bound in the presence of chaotrope. Experiments were conducted to (i) identify the assay with the widest range of AI (discriminatory power), (ii) determine the amount of chaotrope needed to release 50% of bound Ab using plasma from adults and infants, and (iii) evaluate assay repeatability. Results Overall, 4 M GdHCl and 8 M urea were weaker chaotropes than 3 M NH4SCN. For example, they failed to release significant amounts of Ab bound to MSP1-42 in adult plasma samples; whereas, a range of AI values was obtained with NH4SCN. Titration of NH4SCN revealed that 2 M NH4SCN gave the widest range of AI for the 5 antigens. Binding studies using plasma from 40 adults and 57 1-year old infants in Cameroon showed that 2.1 M ± 0.32 (mean ± SD) NH4SCN (adults) and 1.8 M ± 0.23 M (infants) released 50% of bound Ab from the merozoite antigens. Conclusions An avidity MIA is feasible for the 5 merozoite antigens that uses a single concentration (2 M) of NH4SCN. The assay provides a simple method to quickly obtain information about Ab quantity and quality in the acquisition of immunity to malaria in endemic populations.http://link.springer.com/article/10.1186/s12936-020-03243-3MalariaPlasmodium falciparumAntibodiesAntibody avidityMultiplex immunoassayMethods study
collection DOAJ
language English
format Article
sources DOAJ
author Diane Wallace Taylor
Naveen Bobbili
Alex Kayatani
Samuel Tassi Yunga
Winifrida Kidima
Rose F. G. Leke
spellingShingle Diane Wallace Taylor
Naveen Bobbili
Alex Kayatani
Samuel Tassi Yunga
Winifrida Kidima
Rose F. G. Leke
Measuring antibody avidity to Plasmodium falciparum merozoite antigens using a multiplex immunoassay approach
Malaria Journal
Malaria
Plasmodium falciparum
Antibodies
Antibody avidity
Multiplex immunoassay
Methods study
author_facet Diane Wallace Taylor
Naveen Bobbili
Alex Kayatani
Samuel Tassi Yunga
Winifrida Kidima
Rose F. G. Leke
author_sort Diane Wallace Taylor
title Measuring antibody avidity to Plasmodium falciparum merozoite antigens using a multiplex immunoassay approach
title_short Measuring antibody avidity to Plasmodium falciparum merozoite antigens using a multiplex immunoassay approach
title_full Measuring antibody avidity to Plasmodium falciparum merozoite antigens using a multiplex immunoassay approach
title_fullStr Measuring antibody avidity to Plasmodium falciparum merozoite antigens using a multiplex immunoassay approach
title_full_unstemmed Measuring antibody avidity to Plasmodium falciparum merozoite antigens using a multiplex immunoassay approach
title_sort measuring antibody avidity to plasmodium falciparum merozoite antigens using a multiplex immunoassay approach
publisher BMC
series Malaria Journal
issn 1475-2875
publishDate 2020-05-01
description Abstract Background Antibodies (Ab) play a significant role in immunity to Plasmodium falciparum malaria. Usually, following repeated exposure to pathogens, affinity maturation and clonal selection take place, resulting in increased antibody avidity. However, some studies suggest affinity maturation may not occur to malaria antigens in endemic areas. Information on development of antibody avidity is confusing and conflicting, in part, because different techniques have been used to measure avidity. Today, bead-based multiplex immunoassays (MIA) are routinely used to simultaneously quantitate antibody levels to multiple antigens. This study evaluated the feasibility of developing an avidity MIA with 5 merozoite antigens (AMA1, EBA-175, MSP1-42, MSP2, MSP3) that uses a single chaotropic concentration. Methods The most common ELISA protocols that used the chaotropic reagents guanidine HCl (GdHCl), urea, and ammonium thiocyanate (NH4SCN) were adapted to a multiplex MIA format. Then, different concentrations of chaotropes and incubation times were compared and results were expressed as an Avidity Index (AI), i.e., percentage of antibody remaining bound in the presence of chaotrope. Experiments were conducted to (i) identify the assay with the widest range of AI (discriminatory power), (ii) determine the amount of chaotrope needed to release 50% of bound Ab using plasma from adults and infants, and (iii) evaluate assay repeatability. Results Overall, 4 M GdHCl and 8 M urea were weaker chaotropes than 3 M NH4SCN. For example, they failed to release significant amounts of Ab bound to MSP1-42 in adult plasma samples; whereas, a range of AI values was obtained with NH4SCN. Titration of NH4SCN revealed that 2 M NH4SCN gave the widest range of AI for the 5 antigens. Binding studies using plasma from 40 adults and 57 1-year old infants in Cameroon showed that 2.1 M ± 0.32 (mean ± SD) NH4SCN (adults) and 1.8 M ± 0.23 M (infants) released 50% of bound Ab from the merozoite antigens. Conclusions An avidity MIA is feasible for the 5 merozoite antigens that uses a single concentration (2 M) of NH4SCN. The assay provides a simple method to quickly obtain information about Ab quantity and quality in the acquisition of immunity to malaria in endemic populations.
topic Malaria
Plasmodium falciparum
Antibodies
Antibody avidity
Multiplex immunoassay
Methods study
url http://link.springer.com/article/10.1186/s12936-020-03243-3
work_keys_str_mv AT dianewallacetaylor measuringantibodyaviditytoplasmodiumfalciparummerozoiteantigensusingamultipleximmunoassayapproach
AT naveenbobbili measuringantibodyaviditytoplasmodiumfalciparummerozoiteantigensusingamultipleximmunoassayapproach
AT alexkayatani measuringantibodyaviditytoplasmodiumfalciparummerozoiteantigensusingamultipleximmunoassayapproach
AT samueltassiyunga measuringantibodyaviditytoplasmodiumfalciparummerozoiteantigensusingamultipleximmunoassayapproach
AT winifridakidima measuringantibodyaviditytoplasmodiumfalciparummerozoiteantigensusingamultipleximmunoassayapproach
AT rosefgleke measuringantibodyaviditytoplasmodiumfalciparummerozoiteantigensusingamultipleximmunoassayapproach
_version_ 1724915793091624960